Get the Stockscreener App
0.741
6.73%
-0.0535
Calidi Biotherapeutics Inc stock is traded at $0.741, with a volume of 31,231.
It is down -6.73% in the last 24 hours and down -12.01% over the past month.
Calidi Biotherapeutics Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. It engages in advancing a potent allogeneic stem cell capable of carrying an anti-tumor payload for use in multiple oncology indications, including high-grade gliomas and solid tumors. The company's cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Its pipeline of products candidates in the clinic includes NeuroNova that are allogeneic neural stem cells loaded with an oncolytic adenovirus for the treatment of high-grade gliomas; and SuperNova, which are allogeneic adipose-derived mesenchymal stem cells loaded with tumor-selective CAL1 oncolytic vaccinia virus for the treatment of advanced metastatic solid tumors. The company was founded in 2014 and is headquartered in San Diego, California.
See More
Previous Close:
$0.7945
Open:
$0.7945
24h Volume:
31,231
Relative Volume:
0.43
Market Cap:
$5.31M
Revenue:
-
Net Income/Loss:
$-23.36M
P/E Ratio:
-1.0057
EPS:
-0.7368
Net Cash Flow:
-
1W Performance:
-12.41%
1M Performance:
-12.01%
6M Performance:
-53.69%
1Y Performance:
-92.91%
1-Day Range:
$0.741
$0.8151
1-Week Range:
$0.7245
$0.84
52-Week Range:
$0.7245
$19.20
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
Name
Calidi Biotherapeutics Inc
Sector
Industry
Phone
(858) 794-9600
Address
4475 Executive Drive, Suite 200, San Diego
Compare CLDI vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLDI
Calidi Biotherapeutics Inc
|
0.741 | 5.69M | 0 | -23.36M | 0 | -0.7368 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.31 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
763.61 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
722.13 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.36 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
291.71 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-22-23 | Initiated | H.C. Wainwright | Buy |
| Oct-09-23 | Initiated | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc Stock (CLDI) Latest News
Calidi details characterization of CLD-401 for solid tumor treatment - BioWorld MedTech
CLDI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aug PreEarnings: Will Calidi Biotherapeutics Inc. stock recover after earningsJuly 2025 Weekly Recap & Daily Stock Trend Reports - baoquankhu1.vn
Quarterly Earnings: Is Calidi Biotherapeutics Inc a stock for growth or value investors - baoquankhu1.vn
CLDICalidi Biotherapeutics Inc Latest Stock News & Market Updates - Stock Titan
Is Calidi Biotherapeutics Inc. a momentum stockQuarterly Growth Report & Technical Entry and Exit Tips - mfd.ru
Can Calidi Biotherapeutics Inc. keep up with sector leadersJuly 2025 Fed Impact & Weekly Top Performers Watchlists - mfd.ru
Will Calidi Biotherapeutics Inc. stock benefit from AI adoptionEarnings Beat & Pattern Based Trade Signal System - mfd.ru
New virus-based tactic aims to revive T-cell engagers for solid tumors - Stock Titan
Will Calidi Biotherapeutics Inc. stock maintain strong growthEarnings Overview Summary & Safe Capital Investment Plans - mfd.ru
Energy Moves: Why analysts remain bullish on Calidi Biotherapeutics Inc. stockJuly 2025 Gainers & Community Verified Trade Signals - mfd.ru
Calidi Biotherapeutics To Present on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform in a Late-Breaking Abstract at the 2026 AACR-IO Conference - Bitget
Engineered virus from Calidi delivers BiTEs into solid tumors - Stock Titan
Earnings Update: How much upside does Calidi Biotherapeutics Inc haveDividend Hike & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Why analysts remain bullish on Calidi Biotherapeutics Inc. stock2025 Valuation Update & Safe Capital Growth Plans - mfd.ru
Is Calidi Biotherapeutics Inc. a stock for growth or value investorsPortfolio Update Report & Expert Verified Stock Movement Alerts - mfd.ru
What Wall Street predicts for Calidi Biotherapeutics Inc. stock price2025 Investor Takeaways & Community Shared Stock Ideas - mfd.ru
How Calidi Biotherapeutics Inc. stock compares to market leadersTreasury Yields & Free Accurate Trade Setup Notifications - mfd.ru
Can Calidi Biotherapeutics Inc. stock deliver consistent earnings growth - mfd.ru
Calidi Biotherapeutics Updates Corporate Presentation Under Regulation FD - TipRanks
Moving Averages: Why analysts remain bullish on Calidi Biotherapeutics Inc. stockQuarterly Profit Review & Expert Verified Movement Alerts - mfd.ru
Buybacks Report: Is Calidi Biotherapeutics Inc subject to activist investor interestJuly 2025 Technicals & Community Verified Watchlist Alerts - baoquankhu1.vn
Published on: 2026-02-04 07:13:31 - mfd.ru
Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The News-Star
Timing of Immunotherapy Administration May Improve Cancer Treatment Outcomes, Study Suggests - citybuzz -
Calidi Biotherapeutics Sets 2026 Priorities After 2025 Progress - TipRanks
Will Calidi Biotherapeutics Inc. stock go up in YEARJuly 2025 PostEarnings & Fast Gain Swing Trade Alerts - mfd.ru
Published on: 2026-01-29 02:03:05 - baoquankhu1.vn
Calidi Biotherapeutics Provides Corporate Update and Key Value Drivers for 2026 - Yahoo Finance
Is Calidi Biotherapeutics Inc in a consolidation phaseJuly 2025 Spike Watch & Verified Swing Trading Watchlists - baoquankhu1.vn
Merger Talk: What is the fair value of Calidi Biotherapeutics Inc stock nowDip Buying & Daily Entry Point Alerts - Bộ Nội Vụ
What catalysts could drive Calidi Biotherapeutics Inc. stock higher2025 Short Interest & Accurate Buy Signal Alerts - Улправда
Will Calidi Biotherapeutics Inc. stock gain from green policiesDollar Strength & Weekly Stock Breakout Alerts - ulpravda.ru
How sustainable is Calidi Biotherapeutics Inc. stock dividend payoutProfit Target & Daily Momentum Trading Reports - Улправда
Will Calidi Biotherapeutics Inc. stock outperform global peersQuarterly Earnings Summary & Technical Confirmation Trade Alerts - Улправда
How Calidi Biotherapeutics Inc. stock reacts to Fed rate cutsQuarterly Risk Review & Community Trade Idea Sharing Platform - Улправда
Why Calidi Biotherapeutics Inc. stock is rated strong buyJuly 2025 Momentum & AI Optimized Trade Strategies - Улправда
How risky is Calidi Biotherapeutics Inc. stock nowSmall Cap Stock Opportunities & Watch and Learn From Live Trades - ulpravda.ru
United States Oncolytic Viral Therapy Market to hit US$ 164.51 - openPR.com
Will Calidi Biotherapeutics Inc. stock issue positive guidance2026 world cup usa national team third place match playmakers pressing system group prediction tactical review - ulpravda.ru
Calidi Biotherapeutics sinks after pricing $3.9M registered direct offering - MSN
Will Calidi Biotherapeutics Inc. stock outperform international peersEarnings Miss Alerts & Affordable Trading Portfolio - bollywoodhelpline.com
Retail Surge: Will Calidi Biotherapeutics Inc stock outperform international peersJuly 2025 Drop Watch & Fast Gain Swing Trade Alerts - moha.gov.vn
Is Calidi Biotherapeutics Inc. stock positioned for long term growthDebt-to-Equity Ratio Analysis & Free Unlock Rapid Growth Potential - Bollywood Helpline
Bearish Setup: Will Calidi Biotherapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Levels & Weekly Stock Breakout Alerts - Улправда
Calidi Biotherapeutics Earnings Notes - Trefis
Is Calidi Biotherapeutics Inc. stock a smart buy before Fed meeting2025 Support & Resistance & Free Daily Entry Point Trade Alerts - DonanımHaber
Is Calidi Biotherapeutics Inc. stock inflation resilientJuly 2025 Analyst Calls & High Conviction Buy Zone Alerts - DonanımHaber
Will Calidi Biotherapeutics Inc. stock benefit from upcoming earnings reportsWeekly Profit Summary & Stock Portfolio Risk Control - Улправда
Aug Weekly: How risky is Calidi Biotherapeutics Inc. stock nowJuly 2025 PreEarnings & AI Forecast Swing Trade Picks - Улправда
Rally Mode: How risky is Calidi Biotherapeutics Inc. stock nowDollar Strength & Real-Time Sentiment Analysis - Улправда
Calidi Biotherapeutics Inc Stock (CLDI) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.07%
0.71%
Cap:
|
Volume (24h):